New semisynthetic pneumocandins with improved efficacies against Pneumocystis carinii in the rat - Wikidata - awgldk - TriplyDB

New semisynthetic pneumocandins with improved efficacies against Pneumocystis carinii in the rat

New semisynthetic pneumocandins with improved efficacies against Pneumocystis carinii in the rat

http://www.wikidata.org/entity/Q28367755

about

Characterization of a distinct host response profile to Pneumocystis murina asci during clearance of pneumocystis pneumonia Comparison of the echinocandin caspofungin with amphotericin B for treatment of histoplasmosis following pulmonary challenge in a murine model Prophylactic effect of FK463, a novel antifungal lipopeptide, against Pneumocystis carinii infection in mice In vitro and in vivo effects of quinupristin-dalfopristin against Pneumocystis carinii In vitro activities of semisynthetic pneumocandin L-733,560 against fluconazole-resistant and -susceptible Candida albicans isolates Semisynthetic echinocandins affect cell wall deposition of Pneumocystis carinii in vitro and in vivo Cell wall assembly by Pneumocystis carinii. Evidence for a unique gsc-1 subunit mediating beta -1,3-glucan deposition.Antifungal peptides: potential candidates for the treatment of fungal infections.Prevention of infection caused by Pneumocystis carinii in transplant recipients.New and emerging antifungal agents: impact on respiratory infections.Prevention of infection due to Pneumocystis spp. in human immunodeficiency virus-negative immunocompromised patients.Pneumocystis jiroveci pneumonia in adult patients with AIDS: treatment strategies and emerging challenges to antimicrobial therapy.Identification and Functional Ascertainment of the Pneumocystis jirovecii Potential Drug Targets Gsc1 and Kre6 Involved in Glucan Synthesis.Characterization of N-Acetylglucosamine Biosynthesis in Pneumocystis species. A New Potential Target for Therapy.Efficacy of MK-991 (L-743,872), a semisynthetic pneumocandin, in murine models of Pneumocystis carinii.Aerosol and parenteral pneumocandins are effective in a rat model of pulmonary aspergillosis.Evidence for DNA synthesis in Pneumocystis carinii trophozoites treated with the beta-1,3-glucan synthesis inhibitor pneumocandin L-693,989.Pneumocystis workshop: 10th anniversary summary.

P2860

Q24614334-B68B8BE2-DA93-4DD3-97BA-8C7B47EF81A3 Q28344362-5C16C9A6-B559-40FC-A600-3275D629C419 Q28344585-4E34ADC9-E529-4A68-AD50-22A98BA141F2 Q28361588-1CFAE910-6C2E-4DF9-B32A-4E10711F2FF0 Q28378977-A3F8B916-06DD-400C-B7B8-7E55DD6E66F9 Q28379191-89A69479-EC08-4755-8FC5-E7B74C13420C Q30933878-430829CF-E034-4A1D-AE6A-5E941FA6416C Q34074702-611DB99A-F2F2-4953-8E2B-E20328057B93 Q34374874-7F921AE6-2A9A-4B82-9ABF-FBD42DBB4E22 Q35627629-15B763A9-9AF8-4B3E-A0BB-F140CC800BE9 Q35920640-11A46C1C-69E0-4A2D-BAE0-F4C2512DFD3E Q36013688-D9A04AB1-C31E-4722-9E16-FA35730C6B55 Q39177044-925B6469-8E87-4BA3-8616-2853AF86B7C5 Q39386157-6C236A2A-7B31-45E7-97EF-94CD70967E88 Q39558265-EC10CB20-11C2-4E89-AFA5-424CCC25EF20 Q39780220-7B4A61BF-18FF-4394-8045-633F89404FB8 Q42926112-21510114-22E8-4575-AFF8-83988B75D963 Q43145521-69022EF8-EC72-4F57-90BF-B5DBF2984B60

P2860

New semisynthetic pneumocandins with improved efficacies against Pneumocystis carinii in the rat

http://www.wikidata.org/entity/Q28367755

description

1995 nî lūn-bûn

@nan

1995 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

1995 թվականի հունիսին հրատարակված գիտական հոդված

@hy

1995年の論文

@ja

1995年論文

@yue

1995年論文

@zh-hant

1995年論文

@zh-hk

1995年論文

@zh-mo

1995年論文

@zh-tw

1995年论文

@wuu

name

New semisynthetic pneumocandin ...... neumocystis carinii in the rat

@ast

New semisynthetic pneumocandin ...... neumocystis carinii in the rat

@en

New semisynthetic pneumocandin ...... neumocystis carinii in the rat

@nl

type

label

New semisynthetic pneumocandin ...... neumocystis carinii in the rat

@ast

New semisynthetic pneumocandin ...... neumocystis carinii in the rat

@en

New semisynthetic pneumocandin ...... neumocystis carinii in the rat

@nl

prefLabel

New semisynthetic pneumocandin ...... neumocystis carinii in the rat

@ast

New semisynthetic pneumocandin ...... neumocystis carinii in the rat

@en

New semisynthetic pneumocandin ...... neumocystis carinii in the rat

@nl

P1433

Q28367755-D2C6561F-BFCF-483D-BE99-EEAF575B382F

P1476

Q28367755-B6DD9533-63BC-46D3-BB1C-2D49ED0E8D7A

P2093

Q28367755-2DD112AC-2FC5-4347-B2BE-146EEF742089

Q28367755-7925F15B-D072-4F01-AE45-8CBBE88ED4EE

Q28367755-8DFE6426-AF61-451B-8BBA-60D5392ECB19

Q28367755-BA64CCE6-3DCA-41A0-8AE3-FDFD9492592F

Q28367755-BCD12D8E-9348-4CFF-A621-E190C95AA71D

Q28367755-C1AF2B09-8304-4C7D-95B9-6CE5D60FC8C3

Q28367755-EDC304DF-CBC5-4C07-BD0C-3E09156F1EB3

Q28367755-F790FF04-869A-498C-9A4C-359AA3662408

P2860

Q28367755-07B8A95D-11C7-4474-80C5-75D48F8D759D

Q28367755-0B5C8B23-CE37-41AD-9FAF-3D1998AA5135

Q28367755-43FF67CA-1C82-4611-9DE6-E17042BAB7E9

Q28367755-46FAD962-313B-441B-A43A-3A46125BECB3

Q28367755-514BA38C-2F53-42F1-BA18-FF6953B6EA6A

Q28367755-6640ED30-65E6-4032-B7ED-F5969185C631

Q28367755-89A029A9-B416-40D1-B228-E82E704658F3

Q28367755-D30E5CBF-E8AF-457C-AB07-73DD1602375C

Q28367755-D5BB4797-04A3-4CA2-BCB0-085DE6AA3732

Q28367755-D7503A0C-27C0-4346-B881-84149A5FEAF2

P304

Q28367755-7BA55811-2142-4A73-ABFC-9C8887D5B6CF

P31

Q28367755-88FECE27-FBD5-4E78-9993-4C80C1533661

P356

Q28367755-F9A0B4C1-EC85-4BC7-8D79-0F492988030A

P407

Q28367755-15A38750-8AD6-4639-8DB9-E863BDD6567E

P433

Q28367755-C9397AFC-82AF-403C-B8EA-10E459726413

P478

Q28367755-3E49A892-7E1B-4F52-B53E-9AE2B6FA3649

P577

Q28367755-61AC9EB5-9FD8-48B7-B568-1D879F83248D

P698

Q28367755-CAC53474-01AC-4EE2-8CB5-06C7F83920C7

P932

Q28367755-32612F8C-71A2-41B9-9B8A-EB658CB7EDE2

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

New semisynthetic pneumocandin ...... neumocystis carinii in the rat

@en

P2093

D M Schmatz

http://www.w3.org/2001/XMLSchema#string

D McFadden

http://www.w3.org/2001/XMLSchema#string

F A Bouffard

http://www.w3.org/2001/XMLSchema#string

J Andersen

http://www.w3.org/2001/XMLSchema#string

J F Dropinski

http://www.w3.org/2001/XMLSchema#string

K Nollstadt

http://www.w3.org/2001/XMLSchema#string

M A Powles

http://www.w3.org/2001/XMLSchema#string

P Liberator

http://www.w3.org/2001/XMLSchema#string

P2860

In vitro antifungal activities and in vivo efficacies of 1,3-beta-D-glucan synthesis inhibitors L-671,329, L-646,991, tetrahydroechinocandin B, and L-687,781, a papulacandin

Antipneumocystis activity of water-soluble lipopeptide L-693,989 in rats

Synthesis, stability, and biological evaluation of water-soluble prodrugs of a new echinocandin lipopeptide. Discovery of a potential clinical agent for the treatment of systemic candidiasis and Pneumocystis carinii pneumonia (PCP)

Cilofungin (LY121019) inhibits Candida albicans (1-3)-beta-D-glucan synthase activity

In vitro evaluation of the pneumocandin antifungal agent L-733560, a new water-soluble hybrid of L-705589 and L-731373

Aerosolized L-693,989 for Pneumocystis carinii prophylaxis in rats

Synthesis and antifungal activity of novel cationic pneumocandin B(o) derivatives.

Efficacy of cilofungin alone and in combination with amphotericin B in a murine model of disseminated aspergillosis.

Comparative study of antipneumocystis agents in rats by using a Pneumocystis carinii-specific DNA probe to quantitate infection

Use of beta-1,3-glucan-specific antibody to study the cyst wall of Pneumocystis carinii and effects of pneumocandin B0 analog L-733,560.

P304

1320-3

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.39.6.1320

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

39

http://www.w3.org/2001/XMLSchema#string

P577

1995-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

7574523

http://www.w3.org/2001/XMLSchema#string

P932

162734

http://www.w3.org/2001/XMLSchema#string